An Experimental H.I.V. Vaccine Fails in Africanews2021-08-31T11:50:11+00:00August 31st, 2021|The New York Times|
Ivermectin Demand Surges Though It Doesn’t Work for Covid-19news2021-08-30T15:11:24+00:00August 30th, 2021|The New York Times|
Richard Sackler Says Family and Purdue Bear No Responsibility for Opioid Crisisnews2021-08-19T11:38:59+00:00August 19th, 2021|The New York Times|
Purdue Pharma’s Creditors Overwhelmingly Endorse Bankruptcy Plannews2021-07-27T19:29:10+00:00July 27th, 2021|The New York Times|
Johnson & Johnson podría ser menos eficaz contra la variante deltanews2021-07-24T13:00:07+00:00July 24th, 2021|The New York Times|
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggestsnews2021-07-20T21:20:49+00:00July 20th, 2021|The New York Times|
States and Cities Near Tentative $26 Billion Deal in Opioids Casesnews2021-07-20T21:16:11+00:00July 20th, 2021|The New York Times|
How an Unproven Alzheimer’s Drug Got Approvednews2021-07-20T02:12:00+00:00July 20th, 2021|The New York Times|
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patientsnews2021-07-15T03:11:54+00:00July 15th, 2021|The New York Times|
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccinenews2021-07-13T02:28:00+00:00July 13th, 2021|The New York Times|
